News Results
There are 799,676 News Results
Sep 30, 2024
Results from CEPHEUS study highlight DARZALEX FASPRO(®) quadruplet regimen as a potential standard of care in newly diagnosed patients regardless of transplant eligibility
Oct 2, 2024
Largest head-to-head real-world study in mCSPC demonstrated that ERLEADA(®) reduced risk of death by 23 percent at 24 months compared to enzalutamide
Oct 18, 2024
VYLOY is the first and only CLDN18.2-targeted treatment approved in the U.S. for adults with advanced gastric and gastroesophageal junction cancer whose tumors are CLDN18.2 positive
Oct 24, 2024
-- Ribociclib (Kisqali) plus aromatase inhibitor (AI) recommended for HR+/HER2- early breast cancer (EBC) node-positive and high-risk node-negative patients, as studied in the NATALEE trial and indicated by the FDA(1)...
Oct 25, 2024
First-of-its-kind Phase 3b study shows TREMFYA(®) achieved statistical significance across all primary and secondary endpoints in low body surface area psoriasis with special site involvement
Oct 26, 2024
-- New APPEAR-C3G data show Fabhalta sustained proteinuria reduction at 12 months(1) -- Upon Fabhalta initiation, improvement observed in estimated glomerular filtration rate (eGFR) slope - a key measure of...
Oct 28, 2024
A greater number of patients treated with subcutaneous TREMFYA(®) induction and maintenance achieved clinical and endoscopic remission at 48 weeks in the Phase 3 GRAVITI study versus placebo
Oct 30, 2024
MENLO PARK, Calif., Oct. 30, 2024 /PRNewswire/ -- Meta Platforms, Inc. (Nasdaq: META) today reported financial results for the quarter ended September 30, 2024. "We had a good quarter driven...
Nov 4, 2024
BETHESDA, Md., Nov. 4, 2024 /PRNewswire/ -- Centrus Energy Corp. (NYSE American: LEU) ("Centrus") today announced its intention to offer, subject to market conditions and other factors, $350 million aggregate...
Nov 4, 2024
-- Grand Highlander has ample space for people and cargo, including an adult-sized 3(rd) row and 97.5-cu.ft. of storage with second and third row seats folded down -- New Hybrid...
